|
End-of-day quote
Dhaka S.E.
2026-11-03
|
5-day change | 1st Jan Change | ||
| 26.30 BDT | -1.50% |
|
-7.39% | -4.01% |
| Market Cap | 6.69B 53.73M 48M 44.1M 40.05M 75.21M 5.09B 77.1M 526M 212M 2.69B 202M 197M 8.52B | P/E 2024 |
50.8x | P/E 2025 | -17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 32.23B 259M 231M 212M 193M 362M 24.51B 371M 2.53B 1.02B 12.94B 971M 951M 41.01B | EV / Sales 2024 |
3.62x | EV / Sales 2025 | 7.99x |
| Free-Float |
74.17% | Yield 2024 |
1.45% | Yield 2025 | - |
| 1 day | -1.50% | ||
| 1 week | -7.39% | ||
| Current month | -7.07% | ||
| 1 month | -9.31% | ||
| 3 months | -8.36% | ||
| 6 months | +3.14% | ||
| Current year | -4.01% |
| 1 week | 25.8 |  | 29 |
| 1 month | 25.4 | | 31.5 |
| Current year | 23.5 | | 33.2 |
| 1 year | 22.9 | | 33.2 |
| 3 years | 22.9 | | 91.8 |
| 5 years | 22.9 | | 156.5 |
| 10 years | 22.9 | | 156.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zareen Karim
CEO | Chief Executive Officer | 48 | 2019-12-31 |
| Director of Finance/CFO | - | - | |
| Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2014-09-09 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 1984-12-31 |
Hasina Begum
BRD | Director/Board Member | 68 | 1996-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.50% | -7.39% | -15.97% | -66.96% | 49.41M | |
| -0.11% | +9.94% | +57.20% | +148.21% | 1,255B | |
| -1.62% | -0.95% | +42.90% | +75.88% | 641B | |
| -0.98% | -0.14% | +34.93% | +102.23% | 505B | |
| -1.56% | -2.01% | +50.67% | +64.81% | 381B | |
| -2.49% | +2.01% | +75.38% | +39.94% | 357B | |
| -0.02% | +2.11% | +32.16% | +57.79% | 303B | |
| -0.72% | +7.32% | +11.29% | +33.98% | 286B | |
| -0.90% | +2.97% | +55.67% | +70.93% | 249B | |
| -1.68% | +5.27% | +37.21% | +105.26% | 208B | |
| Average | -1.16% | +1.82% | +38.15% | +63.21% | 418.53B | |
| Weighted average by Cap. | -0.94% | +3.90% | +47.24% | +93.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.62B 85.27M 76.18M 69.98M 63.56M 119M 8.08B 122M 835M 336M 4.26B 320M 313M 13.51B | 4.08B 32.77M 29.28M 26.89M 24.43M 45.87M 3.1B 47.02M 321M 129M 1.64B 123M 120M 5.19B |
| Net income | 318M 2.55M 2.28M 2.1M 1.9M 3.57M 242M 3.66M 25.02M 10.06M 128M 9.59M 9.38M 405M | -415M -3.33M -2.98M -2.74M -2.49M -4.67M -316M -4.78M -32.66M -13.14M -167M -12.52M -12.25M -528M |
| Net Debt | 22.31B 179M 160M 147M 133M 251M 16.96B 257M 1.75B 706M 8.95B 672M 658M 28.38B | 25.54B 205M 183M 168M 153M 287M 19.42B 294M 2.01B 808M 10.25B 770M 753M 32.49B |
Employees
2,954
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-03 | BDT 26.30 | -1.50% | 644,729 |
| 26-11-02 | BDT 26.70 | -2.20% | 283,496 |
| 26-11-01 | BDT 27.30 | -3.53% | 485,298 |
| 26-10-29 | BDT 28.30 | -1.39% | 951,661 |
| 26-10-28 | BDT 28.70 | +1.06% | 519,808 |
- Stock Market
- Stocks
- ORIONPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
